Estimates Revisions OSE Immunotherapeutics Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
02:47:23 23/09/26 am AEST
|
Pre-market 03:12:34 pm | |||
| 2.570 EUR | -0.62% |
|
2.595 | +0.97% |
| 21/09 | OSE Immunotherapeutics SA(ENXTPA:OSE) dropped from S&P Global BMI Index | CI |
| 10/09 | OSE Immunotherapeutics: first patient treated in a Phase 2 study |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
OSE Immunotherapeutics(OSE)
EBIT
Dividend / Share (DPS)
Data source:
OSE Immunotherapeutics(OSE)
Cash or Net Debt
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Consensus OSE Immunotherapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
